Clinical Trial Update: Metformin in Parkinson Disease [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial is evaluating metformin for Parkinson's disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Tanta University | Conditions: Parkinson Disease | Phase 2, Phase 3 | Status: RECRUITING